yvejodo.wordpress.com
The company reported $92.4 million in revenue for the quartert endingApril 30, up 2 percent from the same perio d last year. It earned $11 milliojn in net income, or 33 centd per diluted share, during the second quarter, compared with $9.2 million, or 28 centse per diluted share, during the seconx quarter of last year. Analysts polled by expected the company to earn 29 cents per shareand $89 milliob in revenue. Martek (NASDAQ: MATK) sellx nutritional oils derived from algae that are used ininfanf formula, dietary supplements and food products such as yoguryt and juice. Sales of its nutritional supplements to the nursinvg market rose to arecord $9.8 million.
But the company warned that its infant formula sales in the thir d and fourth quarters could drop as retailers trim their inventoriex ofthe product. The company anticipates that infantf formula revenue will grow in fiscal 2010 as a result of strong demanfd for infant formula productsa containing its nutritional oils DHAand ARA. The Omega- fatty acids are believed to play an important role in braibn andeye development. study that could show that Martek’ws DHA can slow the progressionof Alzheimer’s disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment